test

Joseph Cosmai

Euclidean Capital Llc

Assets Managed
$392.311M
Holdings
10
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
6.19%(2Q avg: 30.71%)
Sustained Growth
2 quarters

Portfolio positions

This chart displays the top 10 holdings in Euclidean Capital Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 10 positions.

Assets under management

The assets under management (AUM) of Euclidean Capital Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 392.311M in assets, with a quarterly growth rate of 6.19% and a 2-quarter average growth rate of 30.71%. The portfolio is managed by Joseph Cosmai, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
VEU
Vanguard Ftse All-world Ex-u
Recent Activity
Increased 8.48%
62.09%
$243.586M
3.243M shares@ $75.1 avg price
VTV
Vanguard Value Etf
Recent Activity
26.01%
$102.024M
520,000 shares@ $196.2 avg price
INDA
Ishares Msci India Etf
Recent Activity
4.42%
$17.312M
369,600 shares@ $46.84 avg price
ORIC
Oric Pharmaceuticals Inc
Recent Activity
3.2%
$12.536M
989,410 shares@ $12.68 avg price
FHTX
Foghorn Therapeutics Inc
Recent Activity
1.92%
$7.523M
1.574M shares@ $4.79 avg price
PMVP
Pmv Pharmaceuticals Inc
Recent Activity
0.84%
$3.258M
2.628M shares@ $1.24 avg price
ALEC
Alector Inc
Recent Activity
0.72%
$2.812M
1.308M shares@ $2.16 avg price
SRZN
Surrozen Inc
Recent Activity
0.66%
$2.555M
87,696 shares@ $29.13 avg price
TNYA
Tenaya Therapeutics Inc
Recent Activity
0.18%
$703,274
1.016M shares@ $0.7 avg price
SRZNW
Surrozen Inc-cw25
Recent Activity
0.01%
$2,733
170,833 shares@ $0.02 avg price

1-10 of 10